The role of factor V Leiden mutation in recurrent pregnancy loss.

Jane Cleary-Goldman, Gary S. Nakhuda, Ralf C. Zimmermann, Mark V. Sauer

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Abstract

Although recurrent pregnancy loss is rare, it is a major health problem. Fewer than 50% of cases have definitive causes. Thrombophilias such as factor V Leiden mutation may be responsible for a portion of the unexplained cases. In recent years, a number of studies have reached conflicting conclusions about the role of factor V Leiden in recurrent pregnancy loss. This article reviews the current literature. It appears that factor V Leiden mutation may be associated with stillbirth as well as with some poor pregnancy outcomes. The mutation may also be linked to first-trimester loss. Prospective case-controlled studies to better answer many of the questions concerning the role of this mutation in recurrent pregnancy loss and to determine optimal treatment may not be feasible because it is so rare. At this point, treatment involves anticoagulation and is based on observational studies and expert opinion.

Original languageEnglish (US)
Pages (from-to)165-172
Number of pages8
JournalJournal of the American Medical Women's Association (1972)
Volume58
Issue number3
StatePublished - 2003
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'The role of factor V Leiden mutation in recurrent pregnancy loss.'. Together they form a unique fingerprint.

Cite this